# The New Path Forward for Prior Authorizations: Navigating Differences in the Accepted Standards of Care, Society Guidelines, and FDA-approved Indications

**Authors:** Angel N Desai, Adriana Rauseo, Gerald N Rogan, Andrej Spec, George R Thompson

PMC · DOI: 10.1093/ofid/ofaf765 · Open Forum Infectious Diseases · 2025-12-17

## Full-text entities

- **Diseases:** cryptococcosis (MESH:D003453), nontuberculous mycobacterial infections (MESH:D009165), infectious diseases (MESH:D003141), invasive (MESH:D009361), aspergillosis (MESH:D001228), fungal diseases (MESH:D009181), candidiasis (MESH:D002177), coccidioidomycosis (MESH:D003047), toxicity (MESH:D064420), infection (MESH:D007239), Clostridium difficile (MESH:D003015)
- **Chemicals:** omadacycline (MESH:C000591640), voriconazole (MESH:D065819), posaconazole (MESH:C101425), ketoconazole (MESH:D007654), amphotericin B deoxycholate (MESH:C059765), itraconazole (MESH:D017964), triazole (MESH:D014230), tedizolid (MESH:C546016), fluconazole (MESH:D015725), bedaquiline (MESH:C493870), isavuconazonium (-)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Lomentospora (genus) [taxon 1549750], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12794012/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12794012/full.md

---
Source: https://tomesphere.com/paper/PMC12794012